Ellis IO - Search Results

1

Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma.

Harris GC, Denley HE, Pinder SE, Lee AH, Ellis IO, Elston CW, Evans A. Harris GC, et al. Among authors: ellis io. Am J Surg Pathol. 2003 Jan;27(1):11-5. doi: 10.1097/00000478-200301000-00002. Am J Surg Pathol. 2003. PMID: 12502923

2

The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.

Pinder SE, Ellis IO. Pinder SE, et al. Among authors: ellis io. Breast Cancer Res. 2003;5(5):254-7. doi: 10.1186/bcr623. Epub 2003 Jul 29. Breast Cancer Res. 2003. PMID: 12927035 Free PMC article. Review.

3

An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.

Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO. Dunne B, et al. Among authors: ellis io. Hum Pathol. 2003 Oct;34(10):1009-15. doi: 10.1053/s0046-8177(03)00414-3. Hum Pathol. 2003. PMID: 14608534

4

Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?

Rampaul RS, Pinder SE, Wencyk PM, Nicholson RI, Blamey RW, Robertson JF, Ellis IO. Rampaul RS, et al. Among authors: ellis io. Clin Cancer Res. 2004 Apr 1;10(7):2578. Clin Cancer Res. 2004. PMID: 15073139 No abstract available.

5

Loss of CD55 is associated with aggressive breast tumors.

Madjd Z, Durrant LG, Bradley R, Spendlove I, Ellis IO, Pinder SE. Madjd Z, et al. Among authors: ellis io. Clin Cancer Res. 2004 Apr 15;10(8):2797-803. doi: 10.1158/1078-0432.ccr-1073-03. Clin Cancer Res. 2004. PMID: 15102687

6

Expression of luminal and basal cytokeratins in human breast carcinoma.

Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO. Abd El-Rehim DM, et al. Among authors: ellis io. J Pathol. 2004 Jun;203(2):661-71. doi: 10.1002/path.1559. J Pathol. 2004. PMID: 15141381

7

Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.

Rakha EA, Pinder SE, Paish EC, Robertson JF, Ellis IO. Rakha EA, et al. Among authors: ellis io. J Pathol. 2004 Jul;203(3):754-61. doi: 10.1002/path.1573. J Pathol. 2004. PMID: 15221934

8

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.

Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, Ellis IO. Putti TC, et al. Among authors: ellis io. Mod Pathol. 2005 Jan;18(1):26-35. doi: 10.1038/modpathol.3800255. Mod Pathol. 2005. PMID: 15332092 Free article.

9

Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?

Madjd Z, Durrant LG, Pinder SE, Ellis IO, Ronan J, Lewis S, Rushmere NK, Spendlove I. Madjd Z, et al. Among authors: ellis io. Cancer Immunol Immunother. 2005 Feb;54(2):149-56. doi: 10.1007/s00262-004-0590-0. Epub 2004 Sep 16. Cancer Immunol Immunother. 2005. PMID: 15378282

10

High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.

Rakha EA, Armour JA, Pinder SE, Paish CE, Ellis IO. Rakha EA, et al. Among authors: ellis io. Int J Cancer. 2005 May 1;114(5):720-9. doi: 10.1002/ijc.20738. Int J Cancer. 2005. PMID: 15609312 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

763 results

Search Page